Amounts are shown in US dollars, translated from EUR at the rate recorded for each period. Growth rates marked (EUR) are measured in EUR, the currency the company reports in, so a move in the exchange rate does not count as growth.
Newest figures come from the filing for FY2025, filed Apr 1, 2026. Each column of the statement tables below links to the filing it was taken from.
This page shows SAEN (SAEN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Financial Health Signals
We do not publish a peer-relative financial health score for SAEN, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
SAEN passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
SAEN reported a net loss of $7.7M while operations used $8.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
SAEN's EBITDA was -$7.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior year is not meaningful, because that figure was zero or negative.
SAEN reported a net loss of $7.7M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
SAEN earned -$0.39 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Not reported for fiscal year 2025.
Cash & Balance Sheet
SAEN recorded an outflow of $8.1M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
SAEN held $6.5M in cash against $8.9M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
SAEN's ROE was -29.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 41.4 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
SAEN invested $3.2M in research and development in fiscal year 2025. This represents a decrease of 43.9% in EUR terms from the prior year.
SAEN invested $9K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 70.7% in EUR terms from the prior year.
Not reported for fiscal year 2025.
SAEN Income Statement
Figures in USD, translated from EUR at the rate recorded for each period, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing |
|---|---|---|---|---|---|---|---|
| R&D Expenses | $3.2M-43.9% | $5.0M-26.0% | $7.2M+21.7% | $5.7M+57.5% | $3.8M-27.7% | $5.7M+26.6% | $4.2M |
| SG&A Expenses | $4.6M-21.1% | $5.1M-5.8% | $5.8M-7.8% | $6.1M+148.4% | $2.6M+154.7% | $1.1M-2.1% | $1.0M |
| Operating Income | -$7.8Mn/m | -$10.1Mn/m | -$13.0Mn/m | -$11.8Mn/m | -$6.4Mn/m | -$6.8Mn/m | -$5.2M |
| EBITDA | -$7.7Mn/m | -$10.1Mn/m | -$12.9Mn/m | -$11.8Mn/m | -$6.4Mn/m | -$6.8M | N/A |
| Net Income | -$7.7Mn/m | -$9.2Mn/m | -$12.9Mn/m | -$9.1Mn/m | -$6.3Mn/m | -$6.8Mn/m | -$5.2M |
| EPS (Basic) | N/A | N/A | -$0.71n/m | -$0.50n/m | -$0.42 | N/A | N/A |
| EPS (Diluted) | -$0.39n/m | -$0.51n/m | -$0.71n/m | -$0.50n/m | -$0.42 | N/A | N/A |
| Diluted Shares (Avg) | 20M+7.9% | 18M+0.3% | 18M0.0% | 18M+20.8% | 15M | N/A | N/A |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense, Income Tax.
SAEN Balance Sheet
Figures in USD, translated from EUR at the rate recorded for each period, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing |
|---|---|---|---|---|---|---|---|
| Total Assets | $37.4M+115.1% | $15.3M-33.7% | $24.7M-33.2% | $35.8M-16.5% | $45.3M+128.7% | $21.4M | N/A |
| Current Assets | $35.2M+107.1% | $15.0M-31.9% | $23.5M-33.0% | $33.9M-18.2% | $43.9M+134.4% | $20.2M | N/A |
| Cash & Equivalents | $6.5M+20.6% | $4.7M+24.1% | $4.1M-87.6% | $31.9M-20.0% | $42.1M+140.8% | $18.9M | N/A |
| Short-Term Investments | $26.5M+180.0% | $8.4M-46.4% | $16.7Mn/m | $0n/m | $0n/m | $0 | N/A |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0 | N/A |
| Total Liabilities | $11.8M+331.6% | $2.4M+21.6% | $2.1M-16.7% | $2.5M+97.3% | $1.3M-50.4% | $2.9M | N/A |
| Current Liabilities | $2.5M+0.9% | $2.2M+21.0% | $1.9M-20.5% | $2.3M+92.4% | $1.3M-51.4% | $2.9M | N/A |
| Non-Current Liabilities | $9.3M+3364.4% | $237K+27.7% | $198K+54.3% | $124K+279.5% | $35K+76.1% | $21K | N/A |
| Long-Term Debt | $8.9M | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $25.6M+74.8% | $12.9M-38.8% | $22.6M-34.4% | $33.3M-19.9% | $44.0M+156.5% | $18.5M-19.6% | $21.2M |
| Retained Earnings | -$73.5Mn/m | -$58.0Mn/m | -$52.1Mn/m | -$37.9Mn/m | -$30.6Mn/m | -$26.3M | N/A |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.
SAEN Cash Flow Statement
Figures in USD, translated from EUR at the rate recorded for each period, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$8.1Mn/m | -$6.5Mn/m | -$12.4Mn/m | -$7.9Mn/m | -$7.9Mn/m | -$7.4Mn/m | -$2.8M |
| Depreciation & Amortization | $33K-36.9% | $46K+4.9% | $47K+591.4% | $7K+25.6% | $6K+157.3% | $2K | N/A |
| Stock-Based Compensation | $1.2M+19.2% | $877K+14.5% | $818K+2.4% | $773K+45.4% | $563K+8.0% | $563K-38.6% | $841K |
| Capital Expenditures | $9K+70.7% | $5K-67.6% | $15K-49.1% | $29K+200.5% | $10K-56.8% | $26K | N/A |
| Free Cash Flow | -$8.1Mn/m | -$6.5Mn/m | -$12.4Mn/m | -$8.0Mn/m | -$7.9Mn/m | -$7.4M | N/A |
| Investing Cash Flow | -$17.1M-311.3% | $7.1Mn/m | -$16.5Mn/m | -$29Kn/m | -$10Kn/m | -$26K | N/A |
| Financing Cash Flow | $26.2M+8127.6% | $280K+50914.1% | $587 | N/A | $32.5M+1968.8% | $1.7M-90.6% | $16.6M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
SAEN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing |
|---|---|---|---|---|---|---|---|
| Return on Equity | -29.9%+41.4pp | -71.3%-14.3pp | -57.0%-29.8pp | -27.2%-13.0pp | -14.2%+22.7pp | -36.9%-12.5pp | -24.4% |
| Return on Assets | -20.5%+39.6pp | -60.1%-8.0pp | -52.1%-26.8pp | -25.4%-11.5pp | -13.8%+18.1pp | -31.9% | N/A |
| Current Ratio | 14.16+7.3x | 6.89-5.4x | 12.25-2.3x | 14.53-19.6x | 34.15+27.1x | 7.09 | N/A |
| Debt-to-Equity | 0.35 | N/A | N/A | N/A | N/A | N/A | N/A |
| Liabilities-to-Equity | 0.46+0.3x | 0.19+0.1x | 0.090.0x | 0.070.0x | 0.03-0.1x | 0.16 | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Where SAEN Ranks
Frequently Asked Questions
No, SAEN (SAEN) reported a net loss of $7.7M in fiscal year 2025.
SAEN (SAEN) had EBITDA of -$7.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, SAEN (SAEN) had $6.5M in cash and equivalents against $8.9M in long-term debt.
SAEN (SAEN) has a return on equity of -29.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
SAEN (SAEN) recorded an outflow of $8.1M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
SAEN (SAEN) recorded an outflow of $8.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
SAEN (SAEN) had $37.4M in total assets as of fiscal year 2025, including both current and long-term assets.
SAEN (SAEN) invested $9K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
SAEN (SAEN) invested $3.2M in research and development during fiscal year 2025.
SAEN (SAEN) had a current ratio of 14.16 as of fiscal year 2025, which is generally considered healthy.
SAEN (SAEN) had a debt-to-equity ratio of 0.35 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
SAEN (SAEN) had a liabilities-to-equity ratio of 0.46 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
SAEN (SAEN) had a return on assets of -20.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
SAEN (SAEN) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
SAEN (SAEN) reported a net loss of $7.7M while operations used $8.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.